Management of atrial fibrillation in rheumatic valvular heart disease.
OBJECTIVE
Atrial fibrillation in patients with rheumatic valvular heart disease results in significant morbidity and possibly mortality.


BACKGROUND
The recent advances in treatment options for non-rheumatic atrial fibrillation have widened its scope of management. These treatment modalities have not been extensively validated in rheumatic valvular heart disease.


CONCLUSIONS
A review and comparison of the available data in atrial fibrillation and rheumatic valvular heart disease vis-à-vis non-rheumatic atrial fibrillation is presented.
Vora
Amit
A
Green-gagan, Lokhandwala Township, Kandivli (East), Mumbai, Maharashtra, India. amvora@hotmail.com
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000628:therapy*; D006348:Cardiac Surgical Procedures / Q000379:methods*; D006349:Heart Valve Diseases / Q000150:complications*; D006801:Humans; D012214:Rheumatic Heart Disease / Q000150:complications*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents